Connect Biopharma Holdings Limited (CNTB) Q2 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you for standing by, and welcome to the Connect Biopharma first half 2021 financial results conference call. At this time, all participant lines are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star then one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star then zero. I would now like to hand the conference over to your host today, Matt Steinberg of FinPartners. Please go ahead. Thank you, Operator, and welcome to Connect Biopharma's first half 2021 financial results call. Joining me today is Dr. Zhang Wei, co-founder and CEO, Selwyn Ho, Chief Business Officer, and Eric Hall, Interim CFO. Today's call is being webcast and will be posted on the company's website for playback. During today's call, management will provide an update across our pipeline programs and review our first half 2021 financial results. Following our prepared remarks, we will open the call to Q&A. Before we begin, let me briefly review our forward-looking statements. During today's call, we will make various forward-looking statements. Investors are cautioned that our forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated by our forward-looking statements. Please read the safe harbor statement contained in our press release that we issued yesterday afternoon, as well as risk factors contained in Connect Biopharma's registration statement on Form F-1, for a more complete discussion of these risks and uncertainties. Now, I'd like to turn ...